NRx Pharmaceuticals announced that its BriLife COVID-19 Vaccine is Effectiveness Against Delta Variant.
Information was released by Israel Institute for Biological Research.
Since the pandemic isn`t over, there is a place in the market for new developers that have effective vaccines.
I consider this a premium call, the upside i see here is 400%, or the 24usd...
After a perfect touch of the .618 Fib retracement level, now NRXP is ready to aim higher!
Get ready for action!
My first price target is 35usd.
Today NRx was granted Fast Track Designation by the U.S. Food and Drug Administration for ZYESAMI (aviptadil) for the treatment of Critical COVID-19 with respiratory failure!
NRx Pharmaceuticals has also a Partnership...